Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
about
New combination treatments in the management of asthma: focus on fluticasone/vilanterolOnce-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacyPrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects.Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.Topical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular riskPopulation Pharmacokinetics of Inhaled Fluticasone Furoate and Vilanterol in Subjects with Chronic Obstructive Pulmonary Disease.Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPDOnce-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone.Inhaled corticosteroids for chronic obstructive pulmonary disease.Combination of fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease.Umeclidinium bromide and vilanterol in combination for the treatment of chronic obstructive pulmonary disease.Fluticasone furoate/vilanterol: a review of its use in chronic obstructive pulmonary disease.Fluticasone furoate and vilanterol inhalation powder for the treatment of chronic obstructive pulmonary disease.Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol.Vilanterol trifenatate for the treatment of COPD.Tailoring of corticosteroids in COPD management.The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterol.Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences
P2860
Q26852898-9660C3CC-A43F-4842-B0B5-685ACC84361BQ27010444-3DF6DC80-7257-45E1-9360-DF84EF7295B5Q27348844-73FF4B0E-B983-4CE4-AA58-B6ECF2E2AD49Q30430396-6C73C153-B298-4E47-A9B1-1FA102487CA1Q34636952-9ACC6D84-2E80-44AB-BE34-11FCD993A82DQ35843367-30EF948D-B1AA-43A3-AD30-2C841588D5BCQ36388517-0B72E99E-7D29-4384-9FFC-58F0F8C420DFQ36412770-1BBD2A84-4CF5-4B27-ADC0-4D0DA3E9CC16Q37429593-BBA65476-DF73-41AE-A157-5A3EDCB9C7D3Q37614090-0D5F6A83-160F-4C29-A698-FA71669BE6C4Q37658668-A5F2B1CD-6F1B-495D-9326-A4C497A2B78EQ38153757-AA37E526-3B96-4112-8F26-01137739664EQ38164675-C68F36C0-D80B-4FDF-8E4F-91DCE1E9BFC2Q38218619-D7D8FC85-07BE-43CA-A9BB-F45D4B7E9AF4Q38235191-DFC6DC4A-DEBC-49FB-91E4-EED27DFF8A69Q38284373-8E3D9580-4CF5-49BB-ACD5-BD265EDF4FA3Q38352425-4CFF4316-83B1-4336-8DA0-BFFDE76C3C21Q38824916-C39954F7-8A6B-477E-B6A7-E49E5A355C03Q42753079-328B4449-F0D0-41F4-A8B9-2C02D9B17457Q51671642-952E1EE2-A213-4826-8855-3DB82688F064Q58784324-3C875B35-6414-4510-BD1F-3E0C12420B07
P2860
Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effect of once-daily fluticaso ...... mplete block, crossover study.
@en
type
label
Effect of once-daily fluticaso ...... mplete block, crossover study.
@en
prefLabel
Effect of once-daily fluticaso ...... mplete block, crossover study.
@en
P2093
P1476
Effect of once-daily fluticaso ...... mplete block, crossover study.
@en
P2093
Courtney Crim
Joseph A Boscia
Krishna K Pudi
Lisa Sanford
Michael T Zvarich
Sarah K Siederer
P304
1655-66.e5
P356
10.1016/J.CLINTHERA.2012.06.005
P577
2012-07-11T00:00:00Z